Spots Global Cancer Trial Database for Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

Official Title: Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

Study ID: NCT00260559

Conditions

Esophagectomy

Esophageal Cancer

Interventions

Questionnaires

Study Description

Brief Summary: To assess short and long term outcomes after minimally invasive esophagectomy compared to open esophagectomy. To compare both standard outcome measures as well as patient derived outcome measures, in particular, quality of life (QOL). To look at the applicability of this QOL instrument to this patient group.

Detailed Description: Assess short and long term outcomes after minimally invasive esophagectomy(MIE) compared to open esophagectomy. Measure standard observer derived outcomes such as morbidity, mortality, tumor recurrence and also patient derived outcomes, in particular quality of life (QOL) using the MOS SF36 questionnaire. Evaluate whether the SF36 will accurately reflect pre and postoperative changes in clinical status in this patient group.Compare the results of this global QOL instrument (SF 36) to disease specific scales of dysphagia and reflux. Assess the impact of adjuvant or neoadjuvant therapy on QOL in this patient group and determine if any advantages of MIE can be demonstrated.